Previously Profiled
A&C is a global GMP manufacturer of excipients, buffers, process solutions and a select number of APIs.
Ceapro develops and commercializes functionally active ingredients for human and animal health, using proprietary technology and renewable and sustainable resources.
GIC, an Edmonton-based company, specializes in the production of batch quantities of organic bio-molecules for the pharmaceutical industry.
FREDSENSE, an Alberta corporation headquartered in Calgary, is aiming to revolutionize water quality monitoring, through synthetic biology.
ARCI is headquartered in Edmonton and provides knowledge-based drug discovery services to major biotech, pharma and research organizations.
Gowlings, a leading international law firm, provides a full-range of legal services to meet the needs of clients in the life sciences.
AVAC establish new agricultural investment arm ~Verdex Capital~ to leverage investment opportunities in the field of agricultural technology.
Congratulate NanoSpeed, as they have announced two Distribution Partnerships for Point of Care Vitamin D Deficiency Test- Test4D™
Translational Laboratories exists to help meet the needs of sophisticated sample analysis beyond the reach of small labs and startup firms.
Congratulate Alberta Glycomics Centre for Their Leadership in the Collaborative Successful Funding of $27.3M for GlycoNet- A Canadian Glycomics Network
Exciton Technologies Inc. and their product, exsalt® wound dressing has been featured on Global News Health Matters
Bertech Diagnostics Ltd. Licenses the Lung Cancer Test™ for the Canadian Market
Need an engineering service that has ISO13485 certification? Go to Tangent Design Engineering for mechanical design and product development.
The Precision Broiler Breeder Feeding System - a new technology coming out of the Poultry Research Center
Congratulate Dr. Bernhard Seifried of Ceapro Inc., recipient of the BioAlberta Scientific Achievement & Innovation Award.
Congratulate BioNeutra, awarded Company of the Year at BioAlberta’s 2014 Awards Gala
Frost & Sullivan Recognizes MTI’s Revolutionary PolypDx, a Screening Test for Early Indication of Colorectal Cancer
Developing treatments for patients with cardiovascular disease, diabetes mellitus, Alzheimer's disease, peripheral artery disease, and chronic kidney disease.
Innovative Trauma Care (iTraumaCare™) announces new President and CEO